Parexel CEO reflects on Pfizer deal

By Gareth Macdonald

- Last updated on GMT

Parexel CEO reflects on Pfizer deal
Parexel CEO Josef von Rickenbach predicts more Big Pharma strategic partnerships.

Von Rickenbach spoke with Outsourcing-pharma.com about the new strategic deal Parexel signed with Pfizer last week.

He described the deal with Pfizer, which will focus on the provision of trial services, as a “nice win” for Parexel that will help the firm achieve a double digit growth rate by spring of next year.

Von Rickenbach added that, while details of the accord are still to be worked out, he does not expect early-phase development to be a core focus and added that the previously announced plan to reduce the CRO's Phase I capacity was still necessary.

He also said that it is too early to say if the partnership will involve the transfer of assets and personal or if Parexel is one of the CROs Pfizer hopes to install at the R&D facility in Sandwich, UK that it plans to close in 2012​.

Strategic deals

Von Rickenbach also spoke about the wider trend for strategic partnerships between CROs and pharmaceutical developers, explaining that deals the firm already has in place are “working out better then our clients expected”.

My anticipation is that you will continue to see this trend play out. I think maybe we are a third into it and I would not be surprised if we see several more Big Pharmas adopt similar partnerships.”

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us

Products

View more

Webinars